pancan.ai/Ask
what is known about trial:nct:NCT06782932
Understood asRecord NCT06782932View getStudy → table
Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer NCT06782932↗ Outcome: Ongoing
Computed from the knowledge API (getStudy); every record links to its source.